Your browser doesn't support javascript.
loading
Predictors of pneumococcal vaccination among Australian adults at high risk of pneumococcal disease.
Trent, Mallory J; Salmon, Daniel A; MacIntyre, C Raina.
Afiliação
  • Trent MJ; Biosecurity Program, The Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: mallory.trent@unsw.edu.au.
  • Salmon DA; Departments of International Health and Health Behavior Society, Institute for Vaccine Safety, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
  • MacIntyre CR; Biosecurity Program, The Kirby Institute, University of New South Wales, Sydney, Australia.
Vaccine ; 40(8): 1152-1161, 2022 02 16.
Article em En | MEDLINE | ID: mdl-35078659
ABSTRACT

BACKGROUND:

Although nearly all Australian children are vaccinated against pneumococcal disease, pneumococcal vaccine uptake is low among high-risk adults. This study aimed to identify perceived barriers to pneumococcal vaccination among high-risk adults.

METHODS:

This paper reports combined data on pneumococcal vaccination collected from three different online, cross-sectional surveys that were administered in Australia between August 2019 and September 2020. Using Poisson regression, we identified characteristics and beliefs associated with self-reported pneumococcal vaccination among adults aged 65 and over or with chronic health conditions.

RESULTS:

The weighted estimate for pneumococcal vaccine coverage was 24% for high-risk adults under 65 and 53% for adults aged 65 and over. Nearly half of those under 65 reported they had never heard of the pneumococcal vaccine, while 26% of those aged 65 and over had never heard of the vaccine. Among those under 65, pneumococcal vaccination was associated with high perceived disease susceptibility (PR = 1.97, 95% CI 1.23, 3.18), not having heard of the pneumococcal vaccine (PR = 0.44, 95% CI 0.28-0.69), awareness that their chronic health condition puts them at increased risk of pneumonia (PR = 2.44, 95% CI 1.51-3.98), and having a doctor recommend the vaccine (PR = 3.02, 95% CI 2.05-4.44). Among adults aged 65 and over, self-reported pneumococcal vaccination was associated with influenza vaccination in the previous 12 months (PR = 4.28, 95% CI 2.85-6.44) and awareness that they are eligible for free pneumococcal vaccination (PR = 5.02, 95% CI 2.34-10.77).

CONCLUSION:

Awareness of pneumococcal vaccines was low among adults at high risk of pneumococcal disease, which appears to be contributing to low vaccine uptake. A doctor's recommendation was associated with increased uptake of pneumococcal vaccine, so interventions should be developed to promote pneumococcal vaccine uptake in GP practices.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Vacinas contra Influenza / Influenza Humana Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Child / Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Vacinas contra Influenza / Influenza Humana Tipo de estudo: Etiology_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Adult / Aged / Child / Humans País/Região como assunto: Oceania Idioma: En Ano de publicação: 2022 Tipo de documento: Article